Executive summary of the 14th HHT international scientific conference.

Authors:
Ola R; Hessels J; Hammill A; Friday C; Clancy M and 4 more

Journal:
Angiogenesis

Publication Year: 2023

DOI:
10.1007/s10456-023-09886-5

PMCID:
PMC10543799

PMID:
37695357

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Angiogenesis

Abbreviation: Angiogenesis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aging impairs the ability of vascular endothelial stem cells to generate endothelial cells in mice.
Shimizu S; Iba T; Naito H and 5 more (2023) - Transparency Score: 4/6
Damage to endothelial barriers and its contribution to long COVID.
Wu X; Xiang M; Jing H and 3 more (2023) - Transparency Score: 2/6
Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary…
Scherschinski L; Han C; Kim YH and 6 more (2023) - Transparency Score: 3/6
Loss of GLTSCR1 causes congenital heart defects by regulating NPPA transcription.
Han F; Yang B; Chen Y and 10 more (2023) - Transparency Score: 4/6
Pathological angiogenesis: mechanisms and therapeutic strategies.
Dudley AC; Griffioen AW. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare they have no competing interests. Competing interests The authors declare they have no competing interests."

Evidence found in paper:

"Funding J. Hessels: Research funding to institution: Vaderis. Dr. Al-Samkari: Research funding to institution: Agios, Amgen, Novartis, Sobi, Vaderis. Consultancy: Agios, Forma, Novartis, Sobi, Pharmacosmos, Moderna, argenx, Rigel Dr. Adrienne Hammill: Research funding to institution: Novartis, Merck, Cerecor, Venthera, Palvella Consultancy: Novartis, Ideaya, Aytu. Dr. Rosemary Akhurst: Research funding to institution: BioMarin Pharmaceutical Inc."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025